MKT Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
MKT Advisors's ABBV Position: Q3 2026 in Review
MKT Advisors reduced its AbbVie (ABBV) stake by 7.3% in Q3 2026, selling an estimated $40.5K and leaving 2,008 shares worth $547K. The position accounts for 0.18% of the portfolio, ranked #66.
MKT Advisors first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. The position peaked at $664K in Q3 2025. 1,336 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- MKT Advisors held 2,008 shares of AbbVie worth $547K as of Q3 2026.
- MKT Advisors sold 158 AbbVie shares in Q3 2026, an estimated $40.5K.
- AbbVie made up 0.18% of MKT Advisors's portfolio in Q3 2026, its #66 holding.
- MKT Advisors first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- MKT Advisors's AbbVie position peaked at $664K in Q3 2025.
- 1,336 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on MKT Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.